Remarkable Results in the Treatment of Patients with Relapsed Large B-Cell Lymphoma

Directly from ASH21 we offer you an update from the  ZUMA‑7 study, A Phase 3 Randomized Trial of Axi-Cel Treatment for patients with relapsed large B-Cell Lymphoma. The results are remarkable, Axi-Cel Treatment is one of the new treatments for lymphoma patients that will likely become a new paradigm in the future. In this MEDtalk Frederik L. Locke,  sums up the background of the study and presents the convincing results.